Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Sandoz Limited, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom
Budesonide 64 micrograms/actuation, Aqueous Nasal Spray.
| Pharmaceutical Form |
|---|
|
Nasal spray, suspension. White homogeneous suspension. |
The delivered (metered) dose of 0.05 ml nasal spray, suspension contains 64 micrograms of budesonide.
Excipient (s) with known effect: 0.06 mg of potassium sorbate/0.05 ml nasal spray, suspension
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Budesonide |
Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. |
| List of Excipients |
|---|
|
Dispersible cellulose (Microcrystalline cellulose and carboxymethylcellulose sodium, (89:11, w/w)) |
Amber type III glass bottle fitted with a plastic nasal spray pump and polypropylene nasal applicator: pack size of 1 x120 (1 × 10 ml) doses, 3 × 120 (3 × 10 ml) doses, 10 × 120 (10 × 10 ml) doses
Not all pack sizes may be marketed.
Sandoz Limited, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom
PL 04416/0784
30th July 2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
